Hyundai Pharmaceutical Co Ltd

XKRX:004310 (Korea (the Republic of))  
â‚© 4810.00 (-2.53%) Sep 20
46.70
P/B:
1.51
Market Cap:
â‚© 125.71B ($ 94.34M)
Enterprise V:
â‚© 154.01B ($ 115.58M)
Volume:
1.11M
Avg Vol (2M):
4.07M
Trade In:
Volume:
1.11M
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Hyundai Pharmaceutical Co Ltd ( XKRX:004310 ) from 1990 to Sep 21 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Hyundai Pharmaceutical stock (XKRX:004310) PE ratio as of Sep 21 2024 is 46.7. More Details

Hyundai Pharmaceutical Co Ltd (XKRX:004310) PE Ratio (TTM) Chart

To

Hyundai Pharmaceutical Co Ltd (XKRX:004310) PE Ratio (TTM) Historical Data

Total 1233
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Hyundai Pharmaceutical PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-09-22 46.7 2024-07-16 34.4
2024-09-20 46.7 2024-07-15 34.2
2024-09-19 47.9 2024-07-12 34.0
2024-09-13 46.0 2024-07-11 34.2
2024-09-12 46.5 2024-07-10 34.2
2024-09-11 45.9 2024-07-09 33.7
2024-09-10 48.9 2024-07-08 33.8
2024-09-09 43.4 2024-07-05 33.7
2024-09-06 42.0 2024-07-04 33.5
2024-09-05 42.8 2024-07-03 33.9
2024-09-04 43.9 2024-07-02 34.0
2024-09-03 45.8 2024-07-01 34.4
2024-09-02 44.7 2024-06-28 34.3
2024-08-30 44.7 2024-06-27 34.7
2024-08-29 43.1 2024-06-26 34.6
2024-08-28 43.5 2024-06-25 34.6
2024-08-27 44.0 2024-06-24 34.6
2024-08-26 43.9 2024-06-21 34.7
2024-08-23 45.1 2024-06-20 34.8
2024-08-22 43.9 2024-06-19 34.6
2024-08-21 46.5 2024-06-18 34.6
2024-08-20 46.6 2024-06-17 35.7
2024-08-19 48.0 2024-06-14 34.8
2024-08-16 51.0 2024-06-13 35.5
2024-08-14 49.8 2024-06-12 35.5
2024-08-13 51.2 2024-06-11 35.4
2024-08-12 54.3 2024-06-10 35.7
2024-08-09 53.4 2024-06-07 35.4
2024-08-08 52.8 2024-06-05 35.5
2024-08-07 53.8 2024-06-04 35.6
2024-08-06 52.3 2024-06-03 35.6
2024-08-05 49.2 2024-05-31 35.4
2024-08-02 52.9 2024-05-30 35.8
2024-08-01 56.5 2024-05-29 35.9
2024-07-31 52.0 2024-05-28 36.2
2024-07-30 55.0 2024-05-27 21.0
2024-07-29 50.8 2024-05-24 21.1
2024-07-26 49.0 2024-05-23 21.1
2024-07-25 48.6 2024-05-22 21.1
2024-07-24 48.5 2024-05-21 21.1
2024-07-23 46.5 2024-05-20 21.3
2024-07-22 35.8 2024-05-17 21.4
2024-07-19 34.5 2024-05-16 21.4
2024-07-18 34.3 2024-05-14 21.2
2024-07-17 34.5 2024-05-13 21.3

Hyundai Pharmaceutical Co Ltd (XKRX:004310) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Hyundai Pharmaceutical Co Ltd is a South Korea based company engage in the manufacturing and distribution of pharmaceutical products, health foods, and medical equipment.